HUALAN BIOLOGICAL ENGINEERING INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.65 CNY | +0.26% |
|
-0.66% | -11.21% |
| May. 16 | Hualan Biological Engineering's Blood Centers Get License to Operate | MT |
| Apr. 25 | Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Hualan Biological Engineering Inc.
Price target over the last 5 years
History of analyst recommendation changes
ffea47d9818568d714288e8c.9ypstzTq9A89zWse-ZKoKd5Go7fip0258OlI5RfwTLc.n2MK1gXbnjxxhzxPlOjDZbd08_qW4wLoupgv3DqZPse7YlXcedmYX3v_HA~29fb17dc2788643d1b8d88c4ec391abd
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
19.65
CNY
Average target price
25.78
CNY
Spread / Average Target
+31.22%
High Price Target
32
CNY
Spread / Highest target
+62.85%
Low Price Target
19
CNY
Spread / Lowest Target
-3.31%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
- Stock Market
- Equities
- 002007 Stock
- Consensus Hualan Biological Engineering Inc.
